Psychiatric drugs responsible for 90,000 ED visits annually
July 11th 2014Adverse reactions to antipsychotics, antidepressants, sedatives and anxiolytics, lithium salts or stimulant drugs are responsible for almost 90,000 emergency department (ED) visits each year by US adults, according to a study in JAMA Psychiatry.
Read More
Death due to opioid overdose rising in United States
July 11th 2014Drug overdose deaths in the United States increased for the 11th consecutive year in 2010, according to an analysis from the Centers for Disease Control and Prevention (CDC) and. continued to rise in 2011, the most recent year for which data were available.
Read More
In adult patients with type 2 diabetes inadequately controlled on metformin monotherapy-the current standard of treatment- canagliflozin (Invokana) 100 mg and 300 mg reduced relative risk for myocardial infarction (1.6% and 3.0%) and congestive heart failure (2.7% and 4.0%), as compared to sitagliptin 100 mg, according to findings of the health economic simulation analysis presented at the American Diabetes Association (ADA) Scientific Sessions in San Francisco.
Read More
[BLOG] Clinical trial collaborations: An idea whose time has come
July 1st 2014The cost and time commitment to develop new drugs has increased significantly over the last few decades. A variety of factors come into play, but on average, in terms of total expenditures, it has taken from $3 to $5 billion and up to 15 years to bring a new drug to market. Even after all that time and money, with challenging regulatory requirements and other factors, the odds of a new compound making it from the lab to the pharmacy are miniscule. The chance for a new drug to make it to market is a sobering 1 in 5000.
Read More
Patients with diabetic macular edema (DME) treated with aflibercept Injection significantly improved vision and reduced the severity of diabetic retinopathy versus laser photocoagulation, according to data recently presented the American Diabetes Association (ADA) Scientific Sessions in San Francisco.
Read More
[BLOG] Blessings in disguise Should formularies welcome premium-priced bladder cancer drugs?
July 1st 2014The management of bladder cancer represents one of the most costly and underestimated challenges in the oncology spectrum. Despite having the 6th highest incidence of any cancer in the United States, high recurrence rates and the need to constantly monitor patients act as the primary drivers for the high expenditures associated with the disease.
Read More
Palonosetron’s preferred status
June 30th 2014Chemotherapy-induced nausea and vomiting (CINV) is among the most feared adverse effects associated with cancer treatment.1 The likelihood of patients experiencing this entity depends on both patient-related and treatment-related factors. Not all chemotherapeutic products induce equivalent amounts of CINV resulting in the formation of groups contingent on the frequency of CINV in patients receiving a product without antiemetic prophylaxis
Read More
ACIP recommends needle-free, nasal flu vaccine for kids
June 30th 2014The Centers for Disease Control & Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended that when available, the needle-free, nasal flu vaccine (Live Attenuated Influenza Vaccine [LAIV]) should be used for healthy children aged 2 to 8 years, who have no contraindications or precautions.
Read More
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Read More
Michigan merger points to national trend
June 26th 2014ACA’s emphasis on accountable care organizations, patient-centered medical homes, readmission penalties and pricing pressures on hospitals makes it attractive for hospitals to work together to share services and increase the efficiencies
Read More